Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Olanzapine treatment improved quality of life in a patient with fibromyalgia syndrome: a psychological evaluation.

Corallo F, Italiano D, Bonanno L, Baglieri A, Marino S, Bramanti P.

Acta Reumatol Port. 2011 Jul-Sep;36(3):311-2. No abstract available.

PMID:
22113608
[PubMed - indexed for MEDLINE]
Free Article
2.

Atypical antipsychotics in the treatment of fibromyalgia: a case series with olanzapine.

Rico-Villademoros F, Hidalgo J, Dominguez I, García-Leiva JM, Calandre EP.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jan;29(1):161-4.

PMID:
15610961
[PubMed - indexed for MEDLINE]
3.

Decreased pain and improved quality of life in fibromyalgia patients treated with olanzapine, an atypical neuroleptic.

Freedenfeld RN, Murray M, Fuchs PN, Kiser RS.

Pain Pract. 2006 Jun;6(2):112-8.

PMID:
17309719
[PubMed - indexed for MEDLINE]
4.

Olanzapine for the treatment of fibromyalgia symptoms.

Kiser RS, Cohen HM, Freedenfeld RN, Jewell C, Fuchs PN.

J Pain Symptom Manage. 2001 Aug;22(2):704-8.

PMID:
11495717
[PubMed - indexed for MEDLINE]
5.

[Effect of antipsychotic drugs on life quality of schizophrenic patients: one year follow-up study].

Fang M, Li L, Zhao J, Chen H, Ye M, Guo X, Lu Z, Sun X, Wang C, Xie S, Hu B, Guo T, Ma C, Wang B, Lü L, Liu N, Deng H, Chen Q, Shang X, Gong F, Zhang X, He X, Zhou J, Zhang Y.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Sep;34(9):850-5. Chinese.

PMID:
19779255
[PubMed - indexed for MEDLINE]
Free Article
6.

Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment?

Beasley CM Jr, Sutton VK, Taylor CC, Sethuraman G, Dossenbach M, Naber D.

J Clin Psychopharmacol. 2006 Feb;26(1):40-4.

PMID:
16415704
[PubMed - indexed for MEDLINE]
7.

Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine.

Voruganti LP, Awad AG, Parker G, Forrest C, Usmani Y, Fernando ML, Senthilal S.

Schizophr Res. 2007 Nov;96(1-3):146-55. Epub 2007 Aug 29.

PMID:
17728106
[PubMed - indexed for MEDLINE]
8.

[Impact of olanzapine on quality of life of patients with schizophrenia: one-year follow-up with the Seville Quality of Life Questionnaire].

Giner J, Bobes J, Cervera S, Leal C, Baca E, Ibáñez E.

Actas Esp Psiquiatr. 2004 Jan-Feb;32(1):1-7. Spanish.

PMID:
14963775
[PubMed - indexed for MEDLINE]
9.

An open-label study of quetiapine in the treatment of fibromyalgia.

Hidalgo J, Rico-Villademoros F, Calandre EP.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):71-7. Epub 2006 Aug 4.

PMID:
16889882
[PubMed - indexed for MEDLINE]
10.

Clinical and pharmacoeconomic evaluation of switch to olanzapine in veterans with schizophrenia or schizoaffective disorder.

Davis LL, Cates ME, Lowe JS, Ward LC, Johnson JD, Williford RB, Ambrose SM, Thomas BL, Kashner TM.

Psychopharmacol Bull. 2008;41(1):85-98.

PMID:
18362873
[PubMed - indexed for MEDLINE]
11.

Asian outpatients with schizophrenia: a double-blind randomized comparison of quality of life and clinical outcomes for patients treated with olanzapine or haloperidol.

Kongsakon R, Trinidad-Oñate P, Chaudhry HR, Raza SB, Leynes CR, Khan IU, Ismail HC, Chan B, Ignacio JC, Rodriguez SC, Lowry AJ, Brnabic AJ, Buenaventura R.

J Med Assoc Thai. 2006 Aug;89(8):1157-70.

PMID:
17048425
[PubMed - indexed for MEDLINE]
12.

Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice: a naturalistic comparative study.

Ritsner M, Gibel A, Perelroyzen G, Kurs R, Jabarin M, Ratner Y.

J Clin Psychopharmacol. 2004 Dec;24(6):582-91.

PMID:
15538118
[PubMed - indexed for MEDLINE]
13.

Factors associated with adherence to treatment with olanzapine and other atypical antipsychotic medications in patients with schizophrenia.

Liu-Seifert H, Osuntokun OO, Feldman PD.

Compr Psychiatry. 2012 Jan;53(1):107-15. doi: 10.1016/j.comppsych.2010.12.003. Epub 2011 Feb 9.

PMID:
21310400
[PubMed - indexed for MEDLINE]
14.

A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration.

Ritchie CW, Chiu E, Harrigan S, MacFarlane S, Mastwyk M, Halliday G, Hustig H, Hall K, Hassett A, O'Connor DW, Opie J, Nagalingam V, Snowdon J, Ames D.

Int J Geriatr Psychiatry. 2006 Feb;21(2):171-9.

PMID:
16416458
[PubMed - indexed for MEDLINE]
15.

Safety and tolerability of olanzapine compared with other antipsychotics in the treatment of elderly patients with schizophrenia: a naturalistic study.

Ciudad A, Montes JM, Olivares JM, Gómez JC; EFESO Study Group.

Eur Psychiatry. 2004 Sep;19(6):358-65.

PMID:
15363475
[PubMed - indexed for MEDLINE]
16.

A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.

Mortimer A, Martin S, Lôo H, Peuskens J; SOLIANOL Sudy Group.

Int Clin Psychopharmacol. 2004 Mar;19(2):63-9.

PMID:
15076013
[PubMed - indexed for MEDLINE]
17.

Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia.

Naber D, Riedel M, Klimke A, Vorbach EU, Lambert M, Kühn KU, Bender S, Bandelow B, Lemmer W, Moritz S, Dittmann RW.

Acta Psychiatr Scand. 2005 Feb;111(2):106-15.

PMID:
15667429
[PubMed - indexed for MEDLINE]
18.

Shift from first generation antipsychotics to olanzapine may improve health-related quality of life of stable but residually symptomatic schizophrenic outpatients: a prospective, randomized study.

Joffe G, Sintonen H, Appelberg B.

Int J Technol Assess Health Care. 2008 Fall;24(4):399-402. doi: 10.1017/S0266462308080525.

PMID:
18828933
[PubMed - indexed for MEDLINE]
19.

Effectiveness and safety of olanzapine in the treatment of schizophrenia among Asian patients switching from conventional antipsychotics.

Lu Z, Hu J, Chen CK, Lan TH, Diokno GL Jr, Lee BY, McElroy H, Harrison G, Ang Q.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):32-40. Epub 2006 Jul 14.

PMID:
16843580
[PubMed - indexed for MEDLINE]
20.

[Olanzapine versus haloperidol: effectiveness in functionality and health state in a sample of Venezuelan patients with schizophrenia].

Adrianzén C, Sánchez M, Córdova J, Castillo I.

Vertex. 2008 Sep-Oct;19(81):254-60. Spanish.

PMID:
19835025
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk